Assessing the OPRA Trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancer [0.03%]
OPRA试验的外科肿瘤医师评估：在直肠癌患者中进行全程新辅助治疗的安全性和可行性
Wini Zambare,Joao Miranda,Natally Horvat et al.
Wini Zambare et al.
The Organ Preservation in patients with Rectal Adenocarcinoma (OPRA) trial was a randomized, non-blinded, phase II prospective study investigating total neoadjuvant therapy (TNT) and a selective "watch-and-wait" (WW) approach in locally adv...
Trends in surgical treatment of stage IV melanoma: A SEER database study [0.03%]
美国监测、流行病学和最终结果数据库中IV期黑色素瘤外科治疗的变迁趋势分析
Orly N Farber,Yu-Jen Chen,George Molina et al.
Orly N Farber et al.
Introduction: Immunotherapy for advanced melanoma has improved survival outcomes and changed the surgical management of this disease. Prior work demonstrated no difference in rates of resection for stage IV melanoma after...
Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burden [0.03%]
用于诊断性腹腔镜检查的结局预测指标：对于因病情负担不适合进行细胞减灭术和超高温腹腔内化学治疗(HIPEC)患者的预后研究
Paula Marincola Smith,Ashlee Seldomridge,Yi-Ju Chiang et al.
Paula Marincola Smith et al.
Introduction: While cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) can improve overall survival (OS) for patients with peritoneal carcinomatosis from appendiceal or colorectal cancer, some...
Unseen burden: Exploring caregiver experiences, barriers, and facilitators in foregut cancer care [0.03%]
隐性负担——探索胃肠道肿瘤照护中的照料者经历、障碍和促进因素
Ioannis Liapis,Jaspinder Sanghera,Michelle Holland et al.
Ioannis Liapis et al.
Introduction: Caregivers play a pivotal role in supporting foregut cancer patients, yet their experiences and the challenges they face are overlooked. Understanding caregivers' experiences and the barriers and facilitator...
Real world experience with omission of therapeutic lymph node dissection in clinical stage III malignant melanoma treated with checkpoint or kinase inhibition systemic therapy [0.03%]
临床三期黑色素瘤患者接受免疫检查点抑制剂或激酶抑制剂系统治疗后，无需进行辅助性淋巴结清扫的现实世界经验
Michael J Kirsch,Elliott J Yee,Patrick Hosokawa et al.
Michael J Kirsch et al.
Background: Management of clinical stage III melanoma, which historically was treated with surgical therapeutic lymph node dissection (TLND), has changed significantly due to the introduction of effective systemic therapi...
Optimal surveillance for detecting sarcoma lung metastasis - A systematic review [0.03%]
检测肉瘤肺转移的最优监测手段-系统综述
Neha Malik,Kate Krause,Emily Z Keung et al.
Neha Malik et al.
Introduction: Accurate diagnosis of lung metastasis for patients with soft tissue sarcoma (STS) can impact overall survival, but there is considerable variability in imaging utilized to detect metastasis. Chest x-ray (CXR...
Ryan A Denu,Christopher D Quintana-Perez,Sintawat Wangsiricharoen et al.
Ryan A Denu et al.
Purpose: Lynch syndrome (LS) is a cancer predisposition syndrome caused by a germline loss-of-function mutation in a mismatch repair (MMR) gene. While sarcomas are not classically considered LS cancers, we investigated th...
Adjuvant breast radiation therapy practice patterns in the United States from 2012-2017 [0.03%]
美国2012年到2017年的辅助乳腺放疗模式
Jaclyn A Gellings,Chandler S Cortina,Julie Kijak et al.
Jaclyn A Gellings et al.
A systematic review of sebaceous carcinoma of the breast from 2000-2023: A rare entity with high recurrence rates [0.03%]
2000-2023年乳腺皮脂细胞癌的系统性回顾：一种罕见且易复发的疾病实体
Lauren N Cohen,Colleen Flanagan,Amanda L Kong et al.
Lauren N Cohen et al.